MedTrace Logo

Prognostic Evaluation of Tumor Volume and Its Changes in Radical Radiotherapy of Advanced NSCLC

NCT03055715 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 346

Last updated 2018-05-02

No results posted yet for this study

Summary

The aim of the study is to retrospectively monitor the 'gross tumor volume' (GTV) before initiation of radiotherapy and its changes during radiotherapy and to correlate them with retrospectively recorded patient data, as well as with prognostic and therapeutic outcome after definite radiotherapy of locally advanced NSCLC in stage UICC III.

Conditions

  • Non Small Cell Lung Cancer Stage III

Sponsors & Collaborators

  • Radiation Oncology Working Group of the German Cancer Society

    collaborator OTHER

  • Martin-Luther-Universität Halle-Wittenberg

    lead OTHER

Principal Investigators

  • Christian Ostheimer, MD · Klinik fuer Strahlentherapie, Martin-Luther-Universitaet Halle-Wittenberg

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2018-04-01
Completion
2018-04-01

Countries

  • Austria
  • Belgium
  • Germany
  • Spain
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03055715 on ClinicalTrials.gov